Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infections after hysterectomy: azithromycin + cefuroxime vs cefuroxime alone
2021-003467-10Phase 4Active
- Sponsor
- Helsinki University Women's Hospital
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in surgical site infection (SSI) and bacterial disease comparing Azithromycin + cefuroxime prophylaxis with Cefuroxime prophylaxis with placebo (2 arms). Primary endpoint: Deep postoperative infections within 30 days. Started Oct 2021; status: active.
02
Drugs
azithromycincefuroxime
03
Conditions
surgical site infection (SSI)bacterial disease
Beyond the preview
Go deeper on 2021-003467-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003467-10.